NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

Alopecia is the condition of hair loss and can occur at any age across the genders. The exact cause of this disorder is still under consideration, but many factors are assumed to be responsible for developing alopecia. The United States and Canada have a major influence on the regional market of North America, whose growth rate has been estimated to be approximately 4.80% CAGR by the end of 2027.

NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027.

North America Alopecia (Hair Loss) Treatment Market by Gender (Male Alopecia Treatment, Female Alopecia Treatment) by Sales Channel (Prescription, Over the Counter) by Treatment Type (Oral Hair Loss Treatment, Tropical Hair Loss Treatment, Other Treatment Type) by Geography.

Request free sample

Alopecia is the condition of hair loss and can occur at any age across the genders. The exact cause of this disorder is still under consideration, but many factors are assumed to be responsible for developing alopecia. The treatment of patterned hair loss may simply be the acceptance of the condition or carry out interventions that can be attempted like, following up on the medications (Finasteride) and hair transplant surgery.

The North American region has undergone a rise in the prevalence of hair loss and a subsequent higher treatment rate. This higher rate of the occurrence of chronic diseases like polycystic ovary syndrome (PCOS), cancer, and rheumatoid arthritis is most likely to be responsible for alopecia.

The United States and Canada have a major influence on the regional market of North America, whose growth rate has been estimated to be approximately 4.80% CAGR by the end of 2027.

The increasing investment in research and development (R&D) and the improved healthcare facilities are expected to contribute to the growth of the North American regional market. The North American Hair Research Society and the American Hair Loss Association researches the treatment of alopecia by involving together scientists from various institutes.

Canada is expected to witness productive growth by 2027, and the key factor responsible for this is the increasing prevalence of chronic diseases like rheumatoid arthritis, the treatment of which results in hair loss. The National Alopecia Areata Foundation is working for Canada, and they are significantly promoting the growth of alopecia market and increasing the level of awareness amongst population regarding alopecia.

The major market players operational in the North American alopecia treatment market are Cipla, Merck & Co., Inc., Alès Groupe, Daiichi Sankyo, Inc., Sun Pharmaceutical Industries Ltd., Vitabiotics Ltd., HCell Inc., Dr Reddy’s Laboratories Ltd., Alpecin, Aclaris Therapeutics Inc., GlaxoSmithKline, Histogen Inc., Johnson and Johnson, Lifes2good and Concert Pharmaceuticals Inc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • TOPICAL HAIR LOSS TREATMENT IS THE MOST POPULAR AMONG CUSTOMERS
      • FEMALE ALOPECIA TREATMENT MARKET HOLDS THE LARGEST MARKET SHARE
      • OVER THE COUNTER IS THE FASTEST GROWING SALES CHANNEL
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • TECHNOLOGICAL ADVANCEMENTS
      • GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
      • CHANGE IN LIFESTYLE LEADING TO A SURGE IN THE USE OF ALOPECIA DRUGS
    • MARKET RESTRAINTS
      • GROWING PREFERENCE TOWARD SURGERIES
      • RESTRICTED APPROVED THERAPIES
    • MARKET OPPORTUNITIES
      • GROWING HEALTHCARE EXPENDITURE
      • RISING PREVALENCE OF ALOPECIA
    • MARKET CHALLENGES
      • ALTERNATIVE HAIR LOSS THERAPIES
  1. MARKET BY GENDER
    • MALE ALOPECIA TREATMENT
    • FEMALE ALOPECIA TREATMENT
  2. MARKET BY SALES CHANNEL
    • PRESCRIPTION
    • OVER THE COUNTER
  3. MARKET BY TREATMENT TYPE
    • ORAL HAIR LOSS TREATMENT
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • TROPICAL HAIR LOSS TREATMENT
      • MINOXIDIL
      • SHAMPOOS
    • OTHER TREATMENT TYPE
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • MARKET TRENDS
      • PLATELET RICH PLASMA THERAPY (PRP)
      • INTRODUCTION OF NEW PRODUCTS
      • INCREASING USAGE OF REGENERATIVE MEDICINE
      • STEM CELL THERAPY USED FOR THE TREATMENT OF HAIR LOSS
      • EMERGENCE OF LASER TECHNOLOGY
    • ALOPECIA TREATMENT PURCHASE DECISION ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACLARIS THERAPEUTIC INC.
      • ALÈS GROUPE
      • ALPECIN
      • CIPLA
      • CONCERT PHARMACEUTICALS INC.
      • DAIICHI SANKYO, INC.
      • DR REDDY’S LABORATORIES LTD.
      • GLAXOSMITHKLINE
      • HCELL INC.
      • HISTOGEN INC.
      • JOHNSON AND JOHNSON
      • LIFES2GOOD
      • MERCK & CO., INC.
      • SUN PHARMACEUTICAL INDUSTRIES LTD.
      • VITABIOTICS LTD.

TABLE LIST

TABLE 1        NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 2        NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)

TABLE 3        NORTH AMERICA MALE ALOPECIA TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA FEMALE ALOPECIA TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY SALES CHANNEL 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA PRESCRIPTION MARKET 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA OVER THE COUNTER MARKET 2019-2027 ($ MILLION)

TABLE 8        NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)

TABLE 9        NORTH AMERICA ORAL HAIR LOSS TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA ORAL HAIR LOSS TREATMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA FINASTERIDE MARKET 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA OTHER ORAL HAIR LOSS TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA TROPICAL HAIR LOSS TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 14      NORTH AMERICA TROPICAL HAIR LOSS TREATMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 15      NORTH AMERICA MINOXIDIL MARKET 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA SHAMPOOS MARKET 2019-2027 ($ MILLION)

TABLE 17      NORTH AMERICA OTHER TREATMENT TYPE MARKET 2019-2027 ($ MILLION)

TABLE 18      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURE LIST

FIGURE 1      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 2      IMPACT OF ALCOHOL ON HAIR LOSS

FIGURE 3      NATIONAL HEALTHCARE SPENDING IN THE UNITED STATES, 2015-2025 (% OF GDP)

FIGURE 4      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY GENDER 2018 & 2027 (%)

FIGURE 5      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY MALE ALOPECIA TREATMENT 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY FEMALE ALOPECIA TREATMENT 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY SALES CHANNEL 2018 & 2027 (%)

FIGURE 8      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY PRESCRIPTION 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY OVER THE COUNTER 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET SHARE BY TREATMENT TYPE 2018 & 2027 (%)

FIGURE 11   NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY ORAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA ORAL HAIR LOSS TREATMENT MARKET BY FINASTERIDE 2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA ORAL HAIR LOSS TREATMENT MARKET BY OTHER ORAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY TROPICAL HAIR LOSS TREATMENT 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA TROPICAL HAIR LOSS MARKET BY MINOXIDIL 2019-2027 ($ MILLION)

FIGURE 16   NORTH AMERICA TROPICAL HAIR LOSS MARKET BY SHAMPOOS 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET BY OTHER TREATMENT TYPE 2019-2027 ($ MILLION)

FIGURE 18   PORTER’S FIVE FORCE MODEL

FIGURE 19   NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 20   THE UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 21   CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY GENDER
    • MALE ALOPECIA TREATMENT
    • FEMALE ALOPECIA TREATMENT
  2. MARKET BY SALES CHANNEL
    • PRESCRIPTION
    • OVER THE COUNTER
  3. MARKET BY TREATMENT TYPE
    • ORAL HAIR LOSS TREATMENT
      • FINASTERIDE
      • OTHER ORAL HAIR LOSS TREATMENT
    • TROPICAL HAIR LOSS TREATMENT
      • MINOXIDIL
      • SHAMPOOS
    • OTHER TREATMENT TYPE

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now